NeuronAlgo
~/backtests/na-nas-l-011 backtest

$ cd /evidence  ·  evidence archive

Backtest evidence

Mirfak

code: NA-NAS-L-011 NasdaQ_Oanda H1 2006-01-02 → 2026-06-19
net $13,305 trades 531 win 55.47%
at-a-glance --summaryok

$ stats --glance

headline performance at a glance

net_profit
Total net profit $13,305
gross profit$41,423
gross loss$28,118
win_rate
55.47%WIN
██████░░░░
Win rate
294W / 236L
profit_factor
1.47PF
█████░░░░░
Profit factor
gross P / gross L
cagr
4.32%CAGR
░░░░░░░░░
CAGR
annualized
max_drawdown
-22.47%MAX DD
██░░░░░░░░
Max drawdown
$2,433
equity_curve --renderok

$ plot --equity

cumulative account equity over the test window

Stored snapshot: 1,062 points; starts at $10,000.00, ends at $23,304.56; observed range $8,398.44–$23,304.56.

x: time · y: equity (USD)● rendered by na-backtest-charts

$ plot --drawdown

underwater equity (peak-to-trough), in account currency — risk per trade is a fixed dollar amount, so a percent axis would shrink every year as the balance grew

x: time · y: drawdown (USD)● rendered by na-backtest-charts
trade_breakdown --analyzepartial

$ trades --breakdown

win/loss split, averages, and streaks

win_loss_split
55.47%win
Wins294
Losses236
Total531
win_vs_loss_size
Avg win$140.89
Avg loss$119.14
Largest win$837.42
Largest loss-$221.40
key_ratios
Profit factor1.47
Win/Loss ratio1.25
Payout ratio1.18
Expectancy$25.06
Avg trade$25.06
Bars in trade16.59
streaks
Max consec wins10
Max consec losses7
Avg consec wins1.00
Avg consec losses1.00
Long vs short breakdown and per-trade distributions are not in the ingested dataset yet.
full_statistics --allok

$ stats --full

complete metric set, grouped by category

$13,305
Net profit
$41,423
Gross profit
$28,118
Gross loss
4.32%
CAGR
6.34
AHPR
$665
Yearly avg profit
$54
Monthly avg profit
$1.78
Daily avg profit
6.65%
Yearly avg return
8.04%
Exposure
531
Trades
$25.06
Avg trade
run.configok

$ cat run.config

parameters used for this run

instrumentNasdaQ_Oanda
timeframeH1
period start2006-01-02
period end2026-06-19
profit in pips201039.94 ticks
strategyview →
Trading financial instruments carries a high level of risk and may not be suitable for all investors. Past performance — including backtested and simulated results — is not indicative of future results. NeuronAlgo provides research and tooling, not financial advice.
nextok

Explore the strategy behind this run

See the full methodology, risk profile, and live track record — or browse every backtest in the library.

Generated from stored backtest metrics · NeuronAlgo research desk

Scroll to Top